Detalhe da pesquisa
1.
Change in Albuminuria and GFR Slope as Joint Surrogate End Points for Kidney Failure: Implications for Phase 2 Clinical Trials in CKD.
J Am Soc Nephrol
; 34(6): 955-968, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36918388
2.
Acute Treatment Effects on GFR in Randomized Clinical Trials of Kidney Disease Progression.
J Am Soc Nephrol
; 33(2): 291-303, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34862238
3.
Association of Treatment Effects on Early Change in Urine Protein and Treatment Effects on GFR Slope in IgA Nephropathy: An Individual Participant Meta-analysis.
Am J Kidney Dis
; 78(3): 340-349.e1, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33775708
4.
Observational study on the incidence of nephrogenic systemic fibrosis in patients with renal impairment following gadoterate meglumine administration: the NSsaFe study.
J Magn Reson Imaging
; 51(2): 607-614, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31287213
5.
Performance of GFR Slope as a Surrogate End Point for Kidney Disease Progression in Clinical Trials: A Statistical Simulation.
J Am Soc Nephrol
; 30(9): 1756-1769, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31292198
6.
Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial.
Lancet
; 389(10084): 2117-2127, 2017 May 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-28363480
7.
Early Change in Urine Protein as a Surrogate End Point in Studies of IgA Nephropathy: An Individual-Patient Meta-analysis.
Am J Kidney Dis
; 68(3): 392-401, 2016 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-27032886
8.
Evaluation of Variation in the Performance of GFR Slope as a Surrogate End Point for Kidney Failure in Clinical Trials that Differ by Severity of CKD.
Clin J Am Soc Nephrol
; 18(2): 183-192, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36754007
9.
A meta-analysis of GFR slope as a surrogate endpoint for kidney failure.
Nat Med
; 29(7): 1867-1876, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37330614
10.
Erosive enterocolitis in mycophenolate mofetil-treated renal-transplant recipients with persistent afebrile diarrhea.
Transplantation
; 75(5): 665-72, 2003 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-12640307
11.
Comparison of peritoneal dialysis and haemodialysis after renal transplant failure.
Nephrol Dial Transplant
; 21(6): 1669-74, 2006 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-16469763
12.
Impact of gastric acid suppressants on cytochrome P450 3A4 and P-glycoprotein: consequences for FK506 assimilation.
Kidney Int
; 67(3): 1152-60, 2005 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-15698457
13.
Influence of SDZ RAD vs. MMF on gastric emptying in renal transplant recipients.
Clin Transplant
; 17(3): 171-6, 2003 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-12780664
14.
Alterations of CYP3A4 and P-glycoprotein activity in vivo with time in renal graft recipients.
Kidney Int
; 66(1): 433-40, 2004 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-15200453
15.
Cessation of steroids in stable renal transplant patients: the Leuven experience.
Clin Transpl
; : 181-9, 2002.
Artigo
em Inglês
| MEDLINE | ID: mdl-12971448
16.
Differential effect of diarrhea on FK506 versus cyclosporine A trough levels and resultant prevention of allograft rejection in renal transplant recipients.
Am J Transplant
; 2(10): 989-92, 2002 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-12484345
17.
Mycophenolate mofetil in IgA nephropathy: results of a 3-year prospective placebo-controlled randomized study.
Kidney Int
; 65(5): 1842-9, 2004 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-15086925
18.
The value of tuberculin skin testing in haemodialysis patients.
Nephrol Dial Transplant
; 19(2): 433-8, 2004 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-14736970